It's no Alibaba, but the Citizens Financial Group offering is important to the market.
VIDEO ON MSN MONEY
The company has successfully deployed its strategy of targeting commercial airplanes as its major future growth driver.
This is a significant milestone for the company, making 777 the fastest twin-aisle airplane ever to reach this mark. It also validates Boeing's strategy to target commercial airplanes as its major growth driver in coming years. Commercial airplanes are the most valuable division at Boeing, accounting for nearly 53% of the stock's value.
Suddenly there's a very good reason why the company is holding on to its mountains of cash.
Johnson & Johnson's recently approved Zytiga continues to score at the expense of Dendreon's Provenge.
Johnson & Johnson's (JNJ) recently approved prostate cancer drug Zytiga continues to impress. On Thursday, the company said the drug improved survival and delayed the progression of cancer in patients with less advanced disease, according to a late-stage study.
For now, the drug is approved only for treatment in men with a late-stage form of prostate cancer who have failed to respond to chemotherapy. But the study was in men with earlier stages of the disease and who had not been treated with chemotherapy. Approval to treat this new prospective patient population could significantly grow the drug's market.
The Iraqi government is unhappy with the independent deal Exxon struck with Kurdistan to explore for oil.
The Iraqi government refuses to recognize deals that foreign oil majors strike with Kurdistan, and Iraq has pressured Exxon to drop the agreement it signed. It's now waiting for an answer, and then will decide whether Exxon should be allowed to bid in its next round of oil exploration licenses.
Two law professors think the government should regulate new financial products as closely as it monitors new drugs.
When Wall Street whizzes come up with new derivatives or other products, they shouldn't be allowed to market them until the government approves, write Eric Posner and E. Glen Weyl in a recent paper. The government should have an agency similar to the Food and Drug Administration that screens financial proposals carefully.
Volume patterns suggest these stocks are good buys for yield- and safety-oriented buyers.
By Tom Aspray
As I noted in January, seasonal analysis indicates that the Select Sector SPDR - Utilities (XLU) "typically tops in late December and bottoms in March." There were also technical signs at the end of 2011 that the best-performing sector in 2011 (up 14.8%) was forming a short-term top.
Even though XLU is down just under 3% in 2012, individual utilities like Dominion Resources (D), which is the ETF's second-largest holding, is down 4.9%. Dominion pays an annual dividend of $2.11, and at the end of 2011, it was yielding 4.02%. Following the correction, it now yields 4.20%.
A study finds patients using a single pharmacy are more likely to connect with pharmacists.
By Zacks Equity Research
Recently, CVS Caremark (CVS) joined Harvard University and Brigham and Women's Hospital in an extensive study on health policy.
They came up with some new ways to save money while being treated. One of their findings was the importance of a single "pharmacy home" for pharmacy customers.
Casino stocks have been on fire the past 2 years, and January's gaming numbers show the momentum isn't slowing.
Gambling revenue in Nevada rose nearly 18.4% in January to nearly $1.04 billion. It was the first $1 billion month for the state in more than three years, according to the Las Vegas Review-Journal.
Some of the increase had to do with the Chinese New Year holiday taking place in January this year instead of February. Las Vegas is among the top 10 places to visit for Chinese New Year, according to a recent report, and the city works hard to lure visitors from mainland China for the celebration.
Brewer aims to make Budweiser the undisputed 'King of Beers.'
These 3 stocks meet the criteria of the pioneer of value investing.
The new iteration of the iPad will only drive the stock higher as owners upgrade, passing their old models on to their children.
Will people buy Apple's (AAPL) iPad 3, and will sales be good enough to propel the stock even higher? Talk about a half-a-trillion-dollar question.
I think they will because we are headed into a world where there's a chicken in every pot and an iPad in the hands of every man, woman and child.
The company plans to sell the Verismo this fall, and says it will maintain a relationship with Green Mountain Coffee Roasters.
Starbucks (SBUX) is jumping into the single-cup brewing market, preparing to launch a home-based machine called Verismo.
The machine (pictured) is slated to launch this fall at specialty stores, at some Starbucks cafes and online. It's a direct hit at the single-cup brewers made popular by Green Mountain Coffee Roasters (GMCR).
In a webcast Thursday afternoon, CEO Howard Schultz said Verismo will differ from Green Mountain's Keurig machines.
Williams-Sonoma is downgraded to 'underperform,' and Angie's List is initiated with a 'buy.'
Thursday's noteworthy upgrades include:
Forget about Facebook. The manufacturer of the iconic Stratocaster is making noise with plans to go public.
Leo Fender, the founder of the Fender Musical Instruments Corp., brought to life the Telecaster, the first commercially successful solid-body electric guitar. It would help make Fender an iconic brand for the rock 'n' roll movement and bring the guitar brand into the pop culture mainstream.
Now Fender is aiming for the U.S. market mainstream via a stock IPO.
Burger chain's results are still outstanding.
McDonald's (MCD) shares are down over 3% in early trading after the company reminded investors it was not immune to the world's economic pressures. The burger chain results were otherwise outstanding.
Comparable sales in the U.S. rose 11.1% in February, fueled by strong demand for Chicken McBites, Filet-O-Fish, coffee beverages and McDonald's breakfast line-up. Sales at stores opened for at least a year rose 4% in Europe, led by gains in the U.K. and Russia. And strength in Australia boosted sales in Asia/Pacific, Middle East and Africa by 2.4%. Systemwide sales for February jumped 9.4%, or 9.7% in constant currencies, helped by the extra day in the month because of leap year.
MORE ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
As geopolitical tensions threaten to spin out of control, investors are wondering how best to position their portfolios for the global turmoil.
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.
[BRIEFING.COM] The stock market finished an upbeat week on a mixed note. The S&P 500 shed less than a point, ending the week higher by 1.3%, while the Dow Jones Industrial Average (+0.1%) cemented a 1.7% advance for the week. High-beta names underperformed, which weighed on the Nasdaq Composite (-0.3%) and the Russell 2000 (-1.3%).
Equity indices displayed strength in the early going with the S&P 500 tagging the 2,019 level during the opening 30 minutes of the action. However, ... More
More Market News
|There’s a problem getting this information right now. Please try again later.|